Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Snider

Showing results (271-280 of 286) with videos related to

Pageof 29
Sort By:
Plos Genetics|October 17, 2015
Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the BrainKai Wang, Ruijuan Xu, Jennifer Schrandt, et al.
Biomolecules|October 3, 2020
Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) StatusAshley J Snider, Michael C Seeds, Laurel Johnstone, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
Group IIA Secreted Phospholipase A <sub>2</sub> Plays a Central Role in the Pathobiology of COVID-19Justin M Snider, Jeehyun Karen You, Xia Wang, et al.
Journal of Lipid Research|May 12, 2017
Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injuryTess V Dupre, Mark A Doll, Parag P Shah, et al.
Vaccine|August 31, 2023
Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trialCynthia J Snider, Khalequ Zaman, Amanda L Wilkinson, et al.
The AAPS Journal|March 31, 2011
Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker WorkshopJane P F Bai, Robert Bell, ShaAvhree Buckman, et al.
Leukemia|August 31, 2016
Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activationA N McCracken, R J McMonigle, J Tessier, et al.
The Lancet. Infectious Diseases|May 13, 2023
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trialAmanda L Wilkinson, Khalequ Zaman, Masuma Hoque, et al.
The Journal of Clinical Investigation|August 24, 2021
Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortalityJustin M Snider, Jeehyun Karen You, Xia Wang, et al.
Vaccine|March 26, 2022
Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021Cynthia J Snider, Liliane Boualam, Graham Tallis, et al.
Pageof 29

Showing results (271-280 of 286) with videos related to

Sort By:
Pageof 29
Plos Genetics|October 17, 2015
Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the BrainKai Wang, Ruijuan Xu, Jennifer Schrandt, et al.
Biomolecules|October 3, 2020
Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) StatusAshley J Snider, Michael C Seeds, Laurel Johnstone, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
Group IIA Secreted Phospholipase A <sub>2</sub> Plays a Central Role in the Pathobiology of COVID-19Justin M Snider, Jeehyun Karen You, Xia Wang, et al.
Journal of Lipid Research|May 12, 2017
Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injuryTess V Dupre, Mark A Doll, Parag P Shah, et al.
Vaccine|August 31, 2023
Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trialCynthia J Snider, Khalequ Zaman, Amanda L Wilkinson, et al.
The AAPS Journal|March 31, 2011
Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker WorkshopJane P F Bai, Robert Bell, ShaAvhree Buckman, et al.
Leukemia|August 31, 2016
Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activationA N McCracken, R J McMonigle, J Tessier, et al.
The Lancet. Infectious Diseases|May 13, 2023
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trialAmanda L Wilkinson, Khalequ Zaman, Masuma Hoque, et al.
The Journal of Clinical Investigation|August 24, 2021
Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortalityJustin M Snider, Jeehyun Karen You, Xia Wang, et al.
Vaccine|March 26, 2022
Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021Cynthia J Snider, Liliane Boualam, Graham Tallis, et al.
Pageof 29